DeccanBridge UAE — Life Sciences & Healthcare
Advancing human
health, responsibly.
DeccanBridge supports UAE pharmaceutical, biotech, medtech and healthcare organisations through the complex intersection of science, regulation, technology and commercial strategy.
The UAE is a growing hub for life sciences innovation.
The UAE's healthcare and life sciences sector is one of the fastest growing in the region, driven by ambitious national strategies including the UAE National Strategy for Wellbeing 2031 and the Dubai Health Strategy 2026. The UAE has a multi-regulator healthcare system: the Ministry of Health and Prevention (MOHAP) oversees federal healthcare regulation, the Department of Health — Abu Dhabi (DOH) regulates the Abu Dhabi health system, and the Dubai Health Authority (DHA) governs healthcare in Dubai. The UAE is attracting global pharmaceutical companies, biotech innovators and medtech pioneers to its world-class free zones, science parks and healthcare cities. Digital health, telemedicine, AI in diagnostics and health data regulation are rapidly evolving, creating both opportunity and complexity for sector participants.
Deccanbridge brings together legal, advisory, assurance and technology professionals who understand the UAE health and life sciences landscape. We help clients bring innovations to market, navigate regulatory pathways, protect intellectual property, ensure data protection compliance and achieve commercial success — with partner-led engagement anchored in our DIFC and ADGM offices.
Sub-sectors we serve
- ✓Pharmaceuticals & biotech
- ✓Medical devices & diagnostics
- ✓Healthcare providers & insurers
- ✓Digital health & healthtech
Key challenges for UAE life sciences & healthcare.
Regulatory & market access
MOHAP registration (Drug Registration & Pharmaceutical Services), DOH and DHA licensing, product registration through the Emirates Drug Establishment (EDE), and health technology assessment create a complex multi-regulatory pathway from innovation to patient access.
Data, AI & digital health
Health data is protected under UAE PDPL, DHA health data regulation and DOH data governance standards. AI as a medical device, telemedicine regulation, electronic health records interoperability and digital health innovation raise novel legal, ethical and technology challenges.
IP, R&D & commercial strategy
Patent protection, compulsory licensing provisions, free zone incentives for R&D, technology transfer, licensing agreements and partnership structures are critical to capturing value from UAE life sciences innovation while managing risk in a globally competitive market.
How we serve UAE life sciences & healthcare.
Legal
IP protection and patent strategy, MOHAP/DOH/DHA regulatory compliance, clinical trial agreements, healthcare provider contracts, licensing and technology transfer, data protection and dispute resolution under UAE law.
Explore legal services →Advisory
Market access and reimbursement strategy, R&D strategy and free zone incentives, digital health commercialisation, healthcare partnership models, operating model design and sustainability strategy.
Explore advisory services →Assurance
Statutory audit, clinical trial financial controls, internal audit, healthcare provider quality assurance and financial reporting advisory for life sciences and healthcare organisations.
Explore assurance services →Technology
Health data UAE PDPL compliance, cybersecurity for healthcare systems, AI governance for medical devices, digital health platform delivery and clinical data analytics.
Explore technology services →Key regulators shaping UAE life sciences & healthcare.
The UAE healthcare regulatory landscape is structured around three key bodies. The Ministry of Health and Prevention (MOHAP) oversees federal healthcare policy, pharmaceutical registration, public health and licensing of health professionals across the UAE. The Department of Health — Abu Dhabi (DOH) regulates all healthcare facilities, insurers and providers in the emirate of Abu Dhabi. The Dubai Health Authority (DHA) performs the same function for Dubai. The newly established Emirates Drug Establishment (EDE) is responsible for regulating pharmaceuticals, medical devices and other health products at the federal level. The UAE PDPL imposes data protection obligations on health data processing, while each health authority has its own data governance standards. Digital health, telemedicine and AI-based medical devices are increasingly regulated through dedicated frameworks.
Our team helps life sciences and healthcare organisations navigate this multi-layered regulatory environment with integrated legal, advisory, assurance and technology support tailored to the sector.
Key UAE regulators & frameworks
- ✓MOHAP — Ministry of Health & Prevention
- ✓DOH — Department of Health Abu Dhabi
- ✓DHA — Dubai Health Authority
- ✓Emirates Drug Establishment (EDE) & UAE PDPL
Our approach.
Understand
We learn your science, your regulatory pathway and the commercial context of your innovation in the UAE market.
Strategise
We build integrated legal, regulatory and commercial strategies that protect and accelerate your pipeline.
Execute
Partner-led delivery across legal, advisory, assurance and technology — anchored in DIFC and ADGM, globally connected.
Sustain
We stay close as regulations, evidence and markets evolve, protecting the value of your innovation.
Life sciences & healthcare FAQ.
What do you do for pharma and life sciences companies?
How do you support clinical and research activity?
What healthcare-delivery work do you handle?
Bringing innovation to patients?
Partner-led response within one UAE business day.
Start the conversation